ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 829

Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia

Amir minerbi1, Stéphanie Chevalier 2, Abraham Anjarkouchian 2, Audrey Moyen 2, Yoram Shir 1 and Mary-Ann Fitzcharles 1, 1Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada, 2School of Human Nutrition, McGill University, Montreal, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: fibromyalgia, microbiome and nutrition

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S075: Fibromyalgia & Other Clinical Pain Syndromes (827–832)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: We have recently reported significant alterations in gut microbiome compositionin women with fibromyalgia (FM). As gut microbiome is affected by diet, differences in nutritional intake may have accounted for these alterations. Furthermore, there are some reports of selected dietary interventions impacting symptoms of FM. FM patients also frequently try various dietary regimens for symptom relief. The aim of this study was to examine the diet of women with FM compared to healthy controls, and to explore possible associations between the intake of certain nutrients, symptoms severity and gut microbiome composition.

Methods: The study population comprised 77 women with FM (by validated 2016 FM criteria) and 79 controls (household contacts, 1st degree relatives, other controls) Measures included: demographics, comorbidities, polysymptomatic distress scale and quality of life (FIQ). Dietary intake was assessed using the NIH Automated Self-Administered 24-hour recall, following dietician instruction and completion of three-day dietary recall. Datasets with at least two complete days were retained (n=146) and daily nutrient averages were calculated. Under-reporters were excluded from analysis. The Healthy Eating Index (HEI-2015) was calculated to assess diet quality. Intake of micro- and macro-nutrients was correlated with clinical measures of FM using Spearman’s coefficient, and significance was adjusted for multiple comparisons. The gut microbiome was assessed by 16S and whole genome sequencing of stool samples.

Results: There were no differences in demographic and anthropometric characteristics among groups. Significant differences were observed in the abundance of 72 bacterial taxa of the gut microbiome between individuals with FM and controls. Energy and macronutrient intake (total and relative) and overall diet quality score were not different among patients and controls (Table 1). In addition, vitamin, mineral, different fatty acids, alcohol, caffeine, sugar and fiber intakes did not differ among groups; Normalised daily intake of micro- and macro-nutrients showed no significant correlation with demographic and anthropometric measures, disease specific measures, or with the quantities of gut microbiome bacterial taxa differentially abundant in FM.

Conclusion: The gut microbiome of FM patients differed significantly from controls, but without differences in dietary intake. Furthermore macro- and micro-nutrient intake was not correlated with clinical indices of FM, including pain intensity, fatigue, cognitive symptoms and sleep problems. Objective measures of nutrient status, when applicable, would be required to confirm these observations. These data suggest that reported dietary differences between patients and controls are unlikely to explain the differences in gut microbiome or the clinical phenotype of of FM, and add to the emerging body of evidence of a gut-brain axis.


Table 1

Table 1: Daily average intakes of macronutrients. Mean ± SD. Asterisk indicates difference from household members group, p<0.05 ANOVA and Games-Howell post-hoc test.


Disclosure: A. minerbi, None; S. Chevalier, None; A. Anjarkouchian, None; A. Moyen, None; Y. Shir, None; M. Fitzcharles, None.

To cite this abstract in AMA style:

minerbi A, Chevalier S, Anjarkouchian A, Moyen A, Shir Y, Fitzcharles M. Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/dietary-intake-does-not-explain-microbiome-alterations-or-symptom-severity-in-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dietary-intake-does-not-explain-microbiome-alterations-or-symptom-severity-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology